What are the costs of glenohumeral osteoarthritis in the year prior to a total shoulder arthroplasty (TSA)?
- PMID: 31213113
- DOI: 10.1080/00913847.2019.1632159
What are the costs of glenohumeral osteoarthritis in the year prior to a total shoulder arthroplasty (TSA)?
Abstract
Objectives: To identify patterns of health-care utilization and costs associated with management of glenohumeral osteoarthritis in the year prior to undergoing an anatomic total shoulder arthroplasty (ATSA).Methods: The PearlDiver Humana database, an administrative database of Medicare Advantage (MA) and Commercial insurance beneficiaries was queried for active records of patients undergoing a primary ATSA from the fourth quarter of 2010-2015. Pre-operative health-care utilization was categorized as 1) Procedures & Anesthesia, 2) Office visits, 3) Radiology, 4) Injections - a) Steroid injections and b) Hyaluronic Acid (HA) injections, 5) Physical Therapy, 6) Non-opioid pain medications and 7) Opioids. Overall costs/reimbursement and Per-patient average reimbursements (PPARs) were calculated for each category.Results: A total of 3,920 patients (MA = 3,691; Commercial = 229) undergoing primary ATSA were retrieved. Based on defined categories, the total costs prior to ATSA were $368,137 and $2,812,617 for Commercial and MA beneficiaries, respectively. Overall 1-year PPAR for each category was as follows: Procedures & Anesthesia (MA = $1765; Commercial = $5333), Office visits (MA = $441; Commercial = $396); Radiology (MA = $253; Commercial = $558), Injections (MA = $117, Commercial = $173), Physical therapy (MA = $473; Commercial = $372), Non-opioid pain meds (MA = $49; Commercial = $147) and Opioids (MA = $26; Commercial = $49). The highest utilization was seen in the three months prior to ATSA with 42-81% of overall PPAR being accounted for various categories.Conclusion: A high utilization of all health-care resource categories was noted within three months prior to surgery. Providers should consider judicious use of such interventions, particularly in patients which ultimately require surgery in a short frame of time, to reduce the costs associated with the overall episode of care.
Keywords: Humana; TSA; costs; healthcare utilization; pearldiver; pre-operative; total shoulder arthroplasty.
Similar articles
-
Health Care Utilization and Costs in the Year Prior to Arthroscopic Rotator Cuff Repair.Orthop J Sports Med. 2020 Jul 24;8(7):2325967120937016. doi: 10.1177/2325967120937016. eCollection 2020 Jul. Orthop J Sports Med. 2020. PMID: 32782903 Free PMC article.
-
What Are the Costs of Hip Osteoarthritis in the Year Prior to a Total Hip Arthroplasty?J Arthroplasty. 2020 Feb;35(2):313-317.e1. doi: 10.1016/j.arth.2019.09.020. Epub 2019 Sep 19. J Arthroplasty. 2020. PMID: 31601455
-
The Utilization of Formal Physical Therapy After Shoulder Arthroplasty.J Orthop Sports Phys Ther. 2018 Nov;48(11):856-863. doi: 10.2519/jospt.2018.8176. Epub 2018 May 8. J Orthop Sports Phys Ther. 2018. PMID: 29739303
-
Distribution of High-Volume Shoulder Arthroplasty Surgeons in the United States: Data from the 2014 Medicare Provider Utilization and Payment Data Release.J Bone Joint Surg Am. 2016 Sep 21;98(18):e77. doi: 10.2106/JBJS.15.00776. J Bone Joint Surg Am. 2016. PMID: 27655989 Review.
-
Shoulder replacement for osteoarthritis: A review of surgical management.Maturitas. 2018 Feb;108:71-76. doi: 10.1016/j.maturitas.2017.11.013. Epub 2017 Nov 21. Maturitas. 2018. PMID: 29290218 Review.
Cited by
-
Effectiveness of nonoperative treatment in patients with glenohumeral osteoarthritis: a prospective cohort study.JSES Int. 2024 Aug 30;9(2):404-410. doi: 10.1016/j.jseint.2024.08.189. eCollection 2025 Mar. JSES Int. 2024. PMID: 40182250 Free PMC article.
-
Glenohumeral Osteoarthritis: A Biological Advantage or a Missed Diagnosis?J Clin Med. 2024 Apr 18;13(8):2341. doi: 10.3390/jcm13082341. J Clin Med. 2024. PMID: 38673614 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials